GFM
NGNE icon

GF Fund Management’s Neurogene NGNE Stock Holding History

GF Fund Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4K Sell
332
-8
-2% -$220 ﹤0.01% 535
2026
Q1 		$6.85K Buy
340
+38
+13% +$736 ﹤0.01% 587
2025
Q4 		$6.22K Sell
302
-14
-4% -$348 ﹤0.01% 610
2025
Q3 		$5.48K Sell
316
-52
-14% -$1.04K ﹤0.01% 605
2025
Q2 		$5.5K Hold
368
– – ﹤0.01% 620
2025
Q1 		$4.31K Buy
368
+56
+18% +$973 ﹤0.01% 630
2024
Q4 		$7.13K Buy
+312
New +$11.6K ﹤0.01% 585

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

GF Fund Management's NGNE Position: Q2 2026 in Review

GF Fund Management reduced its Neurogene (NGNE) stake by 2.4% in Q2 2026, selling an estimated $220 and leaving 332 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #535.

GF Fund Management first reported a position in NGNE in Q4 2024 and has held it in 7 quarters since. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • GF Fund Management held 332 shares of Neurogene worth $10.4K as of Q2 2026.
  • GF Fund Management sold 8 Neurogene shares in Q2 2026, an estimated $220.
  • Neurogene made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #535 holding.
  • GF Fund Management first reported a position in Neurogene in Q4 2024 and has held it in 7 quarters since.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.